Replies to post #144721 on Biotech Values

[DewDiligence]

FDA approves Bayer/ONXX’s Stivarga (f/k/a regorafenib) for mCRC:

http://www.reuters.com/article/2012/09/27/us-bayer-cancer-idUSBRE88Q13820120927

The PDUFA date was about one month from now.